Cidara Therapeutics (NASDAQ:CDTX) Shares Gap Up on Analyst Upgrade
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up before the market opened on Monday after Needham & Company LLC raised their price target on the stock from $36.00 to $54.00. The stock had previously closed at $21.02, but opened at $40.63. Needham & Company LLC currently has a buy rating on […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up before the market opened on Monday after Needham & Company LLC raised their price target on the stock from $36.00 to $54.00. The stock had previously closed at $21.02, but opened at $40.63. Needham & Company LLC currently has a buy rating on […]
